Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -403.03% is 1937% below its 5-year average of -19.79%, around the middle of its 5-year range (-633.44%–-9.60%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.39% above its 12-month average of -430.56%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -403.03%.
RETURN ON EQUITY (ROE)
-403.03%
RETURN ON EQUITY (ROE) AVG TTM
-430.56%
RETURN ON EQUITY (ROE) AVG 3Y
-177.34%
RETURN ON EQUITY (ROE) AVG 5Y
-19.79%
RETURN ON EQUITY (ROE) AVG 10Y
-26.91%
RETURN ON EQUITY (ROE) AVG 15Y
-37.04%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.39%
CURRENT VS 3Y AVG
-127.26%
CURRENT VS 5Y AVG
-1937.00%
CURRENT VS 10Y AVG
-1397.58%
CURRENT VS 15Y AVG
-988.19%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-859.38%
vs the sector median at left
Sanara MedTech Inc.
Market Cap
$321.76M
Return on Equity (ROE)
-403.03%
TTM Avg
-430.56%
3Y Avg
-177.34%
5Y Avg
-19.79%
Market Cap
$322.71M
Return on Equity (ROE)
N/A
TTM Avg
-541.42%
3Y Avg
-296.61%
5Y Avg
-205.57%
Market Cap
$324.76M
Return on Equity (ROE)
-226.56%
TTM Avg
-87.78%
3Y Avg
-55.09%
5Y Avg
-55.09%
Market Cap
$318.43M
Return on Equity (ROE)
-41.02%
TTM Avg
-44.84%
3Y Avg
-46.96%
5Y Avg
-38.83%
Market Cap
$329.37M
Return on Equity (ROE)
-86.10%
TTM Avg
-112.93%
3Y Avg
-76.30%
5Y Avg
-62.48%
Market Cap
$330.19M
Return on Equity (ROE)
-320.77%
TTM Avg
-82.83%
3Y Avg
-78.63%
5Y Avg
-104.90%
Market Cap
$311.90M
Return on Equity (ROE)
N/A
TTM Avg
34.79%
3Y Avg
145.50%
5Y Avg
100.23%
Market Cap
$309.19M
Return on Equity (ROE)
-25.73%
TTM Avg
-32.35%
3Y Avg
-2448.72%
5Y Avg
-1749.34%
Market Cap
$344.04M
Return on Equity (ROE)
-29.98%
TTM Avg
-145.74%
3Y Avg
-129.76%
5Y Avg
-105.96%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sanara MedTech Inc. (SMTI) | $321.76M | -403.03% | -430.56% | -177.34% | -19.79% |
| Avita Medical Inc. (RCEL)vs › | $322.71M | N/A | -541.42% | -296.61% | -205.57% |
| CapsoVision, Inc. (CV)vs › | $324.76M | -226.56% | -87.78% | -55.09% | -55.09% |
| C4 Therapeutics, Inc. (CCCC)vs › | $318.43M | -41.02% | -44.84% | -46.96% | -38.83% |
| Cabaletta Bio, Inc. (CABA)vs › | $329.37M | -86.10% | -112.93% | -76.30% | -62.48% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $330.19M | -320.77% | -82.83% | -78.63% | -104.90% |
| Agenus Inc. (AGEN)vs › | $311.90M | N/A | 34.79% | 145.50% | 100.23% |
| Benitec Biopharma Inc. (BNTC)vs › | $309.19M | -25.73% | -32.35% | -2448.72% | -1749.34% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | -29.98% | -145.74% | -129.76% | -105.96% |
| Turn Therapeutics Inc. (TTRX)vs › | $346.73M | -1229.58% | 464.26% | -581.37% | -581.37% |
ROE
-403.0%
ROA
-46.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -403.03% |
| 2026-03-31 | -477.72% |
| 2025-12-31 | -633.44% |
| 2025-09-30 | -610.53% |
| 2025-06-30 | -28.07% |
| 2025-03-31 | -31.16% |
| 2024-12-31 | -24.53% |
| 2024-09-30 | -21.02% |
| 2024-06-30 | -15.74% |
| 2024-03-31 | -11.29% |
| 2023-12-31 | -9.60% |
| 2023-09-30 | -18.44% |
| 2023-06-30 | -20.86% |
| 2023-03-31 | -14.38% |
| 2022-12-31 | -18.98% |
| 2022-09-30 | -16.23% |
| 2022-06-30 | -21.90% |
| 2022-03-31 | -34.00% |
| 2021-12-31 | -25.85% |
| 2021-09-30 | -13.63% |
| 2021-06-30 | -10.67% |
| 2021-03-31 | -10.29% |
| 2020-12-31 | -70.83% |
| 2020-09-30 | -95.20% |
| 2020-06-30 | -90.07% |
| 2020-03-31 | -66.17% |
| 2019-12-31 | -42.55% |
| 2018-12-31 | -54.01% |
| 2018-09-30 | 8.43% |
| 2018-06-30 | 13.62% |
| 2018-03-31 | 16.79% |
| 2017-12-31 | 323.11% |
| 2014-03-31 | -924.29% |
| 2011-09-30 | -177.65% |
| 2011-06-30 | -169.80% |
| 2011-03-31 | -123.36% |
| 2010-12-31 | -178.96% |
| 2010-09-30 | -210.98% |
| 2010-06-30 | -136.06% |
| 2010-03-31 | -116.22% |
| 2009-12-31 | -100.44% |
| 2009-09-30 | -58.20% |
